5,670 video views
Loading........
Description:
Dr. J.J. Kiladjian ASH 2018 Headline Research Studies
13:43
Dr. J.J. Kiladjian ASH 2018 Headline Research Studies
by:PVReporter | 220 views
08:25
Ruxopeg Phase 1-2 Trial of Ruxolitinib and Pegasys in Patients with Myelofibrosis
by:PVReporter | 110 views
15:02
Real World Risk Assessment and Treatment of patients with Myelofibrosis at Community Oncology Practices in the U.S.
by:PVReporter | 153 views
08:54
Ropeginterferon Alfa-2b Induces High Rates of Clinical, Hematological and Molecular Responses in PV Patients. Two - year results from the First Prospective Randomized Controlled Trial
by:PVReporter | 457 views
08:37
Advanced Forms of MPNs are Associated with Chromosomal Abnormalities Involved in Disease Progression
by:PVReporter | 252 views
12:00
Patient reported symptom burden and peripheral blood counts among PV patients.
by:PVReporter | 363 views
11:49
Dr Raajit Rampal, Memorial Sloan Kettering Cancer Center in New York City, interviews with David Wallace, PV Reporter. Discussing clinical research in MPNs at ASH 2016. Dr. Rampal presented pre-clinical data from a three drug combo in animal models.
by:PVReporter | 922 views
23:36
Dr Jean Jacques Kiladjian, Professor of Clinical Hematology, Hopital Saint-Louis, Paris, France interviews with David Wallace, PV Reporter at ASH 2016. Discussing Outcomes of Patients with MPNs after Interferon-Alph​a (IFN) Therapy Discontinuation.
by:PVReporter | 833 views

About PVReporter


Links
Channel Url: